Your browser doesn't support javascript.
loading
Coronary artery aneurysm regression after Kawasaki disease and associated risk factors: a 3-year follow-up study in East China.
Tang, Yunjia; Yan, Wenhua; Sun, Ling; Xu, Qiuqin; Ding, Yueyue; Lv, Haitao.
Afiliação
  • Tang Y; The Department of Cardiology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215025, China.
  • Yan W; The Department of Cardiology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215025, China.
  • Sun L; The Department of Cardiology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215025, China.
  • Xu Q; The Department of Cardiology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215025, China.
  • Ding Y; The Department of Cardiology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215025, China.
  • Lv H; The Department of Cardiology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215025, China. haitaoszz@163.com.
Clin Rheumatol ; 37(7): 1945-1951, 2018 Jul.
Article em En | MEDLINE | ID: mdl-29330741
Kawasaki disease (KD) is the leading cause of acquired heart disease due to its complicated coronary artery lesions. Up to now, few studies were focused on the status of persistent coronary artery aneurysms (CAA) in KD patients. The present study was designed to identify the coronary artery outcomes and seek the risk factors associated with the regression of CAA in KD patients. One hundred and twenty KD patients with CAA hospitalized in Children's Hospital of Soochow University from Jan 2008 to Dec 2013 were prospectively studied by a 3-year follow-up. Data regarding demographic, clinical, laboratory, and echocardiographic characteristics were documented and further analyzed. It was estimated that 39.2% of the patients had complete regression of CAA within 4 weeks, 59.2% within 8 weeks, and 70.0% within 16 weeks. No fatal cardiac events occurred. We found patients who aged ≤ 1 year, received initial intravenous immunoglobulin (IVIG) treatment after the 10th day of illness, and IVIG non-responders were associated with the regression of persistent CAA. The relative risks were 1.55, 1.87, and 1.88, respectively. Age, initial IVIG treatment, and IVIG response were risk factors of persistent CAA, and more attention should be paid on these patients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aneurisma Coronário / Imunoglobulinas Intravenosas / Síndrome de Linfonodos Mucocutâneos Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aneurisma Coronário / Imunoglobulinas Intravenosas / Síndrome de Linfonodos Mucocutâneos Idioma: En Ano de publicação: 2018 Tipo de documento: Article